Unlock Drug Development Funding: Up to $500,000 for Innovation
Posted: November 30, 2023
Summary
This grant is for organizations and academic institutions looking to partner with the FDA on groundbreaking drug development research and regulatory science initiatives. Funds will accelerate therapeutic innovation, advanced manufacturing, and improve drug safety and efficacy.
Eligibility
Full Description
This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA.
Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.